News

BIO-CAT Sponsors University of Illinois Clinical Trial of Digestive Enzymes

pvandagriff February 3, 2022 February 11th, 2022

February 2022

Champaign. BIO-CAT’s BC006 efficacy is to be assessed on Postprandial Plasma Nutrient Levels, Gastrointestinal Symptoms, Bowel Function, and Sleep Quality in older adults. Please view the PR Newswire press release here!

News No Comments

Previous PostBIO-CAT Microbials Invests $35 Million in State-of-the-Art Virginia Fermentation Facility
Next PostBIO-CAT Attends IPPE 2022

You must be logged in to post a comment.

BIO-CAT Sponsors University of Illinois Clinical Trial of Digestive Enzymes

Previous PostBIO-CAT Microbials Invests $35 Million in State-of-the-Art Virginia Fermentation Facility

Next PostBIO-CAT Attends IPPE 2022

Leave a Reply

Quick Links

Legal